105 results on '"Takehara, Kazuhiko"'
Search Results
2. Clinical characteristics of four myositis-specific autoantibodies with regulatory-approved testing in Japan: A Japanese multi-centre adult myositis patients’ cohort
3. Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
4. CD22 and CD72 contribute to the development of scleroderma in a murine model
5. CD22 and CD72 cooperatively contribute to the development of the reverse Arthus reaction model
6. Regulatory B1a Cells Suppress Melanoma Tumor Immunity via IL-10 Production and Inhibiting T Helper Type 1 Cytokine Production in Tumor-Infiltrating CD8+ T Cells
7. RXRB Is an MHC-Encoded Susceptibility Gene Associated with Anti-Topoisomerase I Antibody-Positive Systemic Sclerosis
8. A unique CD9 + CD80 + regulatory B cell inhibits contact hypersensitivity response
9. Dual aspects of B cells in tumor immunity; B cells are capable of positive and negative regulation for tumor immunity against B16 melanoma
10. Blockade of p38 Mitogen-Activated Protein Kinase Inhibits Murine Sclerodermatous Chronic Graft-versus-Host Disease
11. Autoantibody to scaffold attachment factor B (SAFB): A novel connective tissue disease-related autoantibody associated with interstitial lung disease
12. Enzyme-linked immunosorbent assays for detection of anti-transcriptional intermediary factor-1 gamma and anti-Mi-2 autoantibodies in dermatomyositis
13. Decreased levels of regulatory B cells in patients with systemic sclerosis: Association with autoantibody production and disease activity
14. The inhibitor of p38 MAP kinase suppresses skin fibrosis in the sclerodermatous chronic GVHD
15. A crucial role of L-selectin in C protein-induced experimental polymyositis of mice
16. A novel splenic B1 regulatory cell subset suppresses allergic disease through phosphatidylinositol 3-kinase–Akt pathway activation
17. B Cells Promote Tumor Immunity against B16F10 Melanoma
18. Blockade of Syk ameliorates the development of murine sclerodermatous chronic graft-versus-host disease
19. B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells
20. Dermokine inhibits ELR+CXC chemokine expression and delays early skin wound healing
21. Chemokine receptors CCR2 and CX3CR1 regulate skin fibrosis in the mouse model of cytokine-induced systemic sclerosis
22. FTY720 ameliorates sclerodermatous chronic GVHD by expansion of splenic regulatory cells and inhibition of skin immune cell infiltration
23. Altered expression of dermokine in skin disorders
24. BLNK expression is essential for IL-10 production in regulatory B cells that inhibit contact hypersensitivity
25. PI3K-Akt pathway modulates IL-10 producing regulatory B cell
26. Circulating γ/δ T cells in systemic sclerosis exhibit activated phenotype and enhance gene expression of proalpha2(I) collagen of fibroblasts
27. Potential Immunologic Targets for Treating Fibrosis in Systemic Sclerosis: A Review Focused on Leukocytes and Cytokines
28. IL-6 Blockade Attenuates the Development of Murine Sclerodermatous Chronic Graft-Versus-Host Disease
29. Basophils and mast cells play critical roles for leukocyte recruitment in IgE-mediated cutaneous reverse passive Arthus reaction
30. Host-Derived MCP-1 and MIP-1α Regulate Protective Anti-Tumor Immunity to Localized and Metastatic B16 Melanoma
31. Plasma CCN2 (connective tissue growth factor; CTGF) is a potential biomarker in idiopathic pulmonary fibrosis (IPF)
32. Inducible Costimulator (ICOS) and ICOS Ligand Signaling Has Pivotal Roles in Skin Wound Healing via Cytokine Production
33. Elevated serum placenta growth factor (PlGF) levels in patients with systemic sclerosis: A possible role in the development of skin but not lung fibrosis
34. Re-emergence of anti-topoisomerase I antibody with exacerbated development of skin sclerosis in a patient with systemic sclerosis
35. Bosentan increases serum IL-12 levels in systemic sclerosis patients with pulmonary arterial hypertension
36. Establishment of Experimental Eosinophilic Vasculitis by IgE-Mediated Cutaneous Reverse Passive Arthus Reaction
37. Clinical association of serum CD137 (4-1BB) levels in patients with systemic sclerosis
38. Association of IL-10 receptor 2 (IL10RB) SNP with systemic sclerosis
39. The Loss of MCP-1 Attenuates Cutaneous Ischemia–Reperfusion Injury in a Mouse Model of Pressure Ulcer
40. Clinical association of serum interleukin-17 levels in systemic sclerosis: Is systemic sclerosis a Th17 disease?
41. Correlation between SPINK5 Gene Mutations and Clinical Manifestations in Netherton Syndrome Patients
42. BAFF Antagonist Attenuates the Development of Skin Fibrosis in Tight-Skin Mice
43. Antiphospholipid antibodies in patients with autoimmune blistering disease
44. Phase-Dependent Roles of E-Selectin during Chronic Contact Hypersensitivity Responses
45. Proteolytic processing of human growth hormone by multiple tissue kallikreins and regulation by the serine protease inhibitor Kazal-Type5 (SPINK5) protein
46. Investigation of the Mechanisms of Pressure Ulcers Using a Cyclical Cutaneous Ischemic–reperfusion Injury Model
47. Establishment of an animal model for allergic granulomatous vasculitis by IgE-mediated cutaneous reverse passive arthus reaction: contribution of selectins and ICAM-1
48. Elevated Human Tissue Kallikrein Levels in the Stratum Corneum and Serum of Peeling Skin Syndrome-Type B Patients Suggests an Over-desquamation of Corneocytes
49. E- and P-Selectins Synergistically Inhibit Bleomycin-Induced Pulmonary Fibrosis
50. B-Lymphocyte Depletion Reduces Skin Fibrosis and Autoimmunity in the Tight-Skin Mouse Model for Systemic Sclerosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.